Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability, and Outcomes of Velpatasvir/SofosbuviR in Treatment of Chronic Hepatitis C Virus During Pregnancy (STORC)

NCT05140941 is registered in ClinicalTrials.gov with Catherine Anne Chappell as lead sponsor.

NCT NCT05140941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05140941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability, and Outcomes of Velpatasvir/SofosbuviR in Treatment of Chronic Hepatitis C Virus During Pregnancy (STORC)
Lead sponsor
Catherine Anne Chappell
Phase
Phase 4
Overall status
Active, not recruiting
Start date
April 4, 2022
Completion date
June 30, 2027
Enrollment
100 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, chronic, pregnancy; infection